Sage Mandel

Direktor/Vorstandsmitglied bei CELYAD ONCOLOGY SA

Consumer Services

Finance

Health Technology

Profil

Sage Mandel currently works at Celyad Oncology SA, as Non-Executive Director.
Ms. Mandel also formerly worked at Essex Woodlands Management, Inc., as Vice President from 2021 to 2023.
Ms. Mandel received her graduate degree in 2015 from the University of Pennsylvania.

Aktive Positionen von Sage Mandel

Unternehmen	Position	Beginn
CELYAD ONCOLOGY SA	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Sage Mandel

Ehemalige bekannte Positionen von Sage Mandel

Unternehmen	Position	Ende
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Private-Equity-Analyst	31.12.2020

Sehen Sie sich die Erfahrung von Sage Mandel im Detail an

Ausbildung von Sage Mandel

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Sage Mandel im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Essex Woodlands Management, Inc. Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position.	Finance
Celyad Oncology SA Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products	Health Technology